Skip to main content
. Author manuscript; available in PMC: 2010 May 26.
Published in final edited form as: Vaccine. 2009 Feb 5;27(25-26):3349–3358. doi: 10.1016/j.vaccine.2009.01.080

Table 6.

HLA class I supertype associations with rubella virus-induced Th1 (IFN-γ, IL-2 and IL-12p40) cytokine immune responses.

Cytokine/HLA locus HLA supertype Number of alleles Median secretion value (pg/ml) Lower Quartile, Q1 (pg/ml) Upper Quartile, Q3 (pg/ml) p-valuea Global p-valuea
IFN-γ Overall 1426 8.53 2.97 23.41
 Class IA 0.865
A1 330 0.334
A2 433 0.370
A3 398 0.948
A24 183 0.961
Otherb 82 0.952
 Class IB 0.881
B7 417 0.369
B27 154 0.785
B44 370 0.520
B58 51 0.436
B62 159 0.619
Otherb 275 0.846
IL-2 Overall 1426 17.59 7.73 30.48
 Class IA 0.203
A1 330 0.226
A2 433 0.427
A3 398 18.92 8.42 31.40 0.017
A24 183 0.718
Otherb 82 0.686
 Class IB 0.557
B7 417 0.378
B27 154 0.553
B44 370 0.537
B58 51 0.418
B62 159 0.164
Otherb 275 0.535
IL-12p40 Overall 1422 0.00 −7.15 7.17
 Class IA 0.633
A1 329 0.656
A2 432 0.752
A3 396 0.644
A24 183 0.111
Otherb 82 0.964
 Class IB 0.593
B7 415 0.148
B27 154 0.628
B44 369 0.889
B58 51 0.567
B62 159 0.778
Otherb 274 0.149

Q1 and Q3 represent the first (25th percentile) and third (75th percentile) quartiles, respectively. Statistically significant findings (p < 0.05) are bolded.

a

Linear regression analysis. p-values for cytokine levels were based on inverse cumulative normal transformation. Analyses adjust for age at blood draw, gender, race, age at first rubella vaccine, age at second rubella vaccine, and cohort status.

b

“Other” includes the following HLA-A alleles: *0217, *0302, *2407, *2608, *2901, *2902, *3004, *3206, *3303, *3401, *6601, *6803, *7401; HLA-B alleles: *0706, *0714, *0801, *1507, *1511, *1522, *1525, *1801, *1803, *1813, *3504, * 3508, *3511, *3512, *3523, *3542, *3906, *4002, *4102, *4201, *4427, *4404, *4405, *4701, *4803, *5703, respectively.